Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motif
The FEBS Journal · 2026
DOI: 10.1111/febs.70566 ↗At a glance
Journal article in The FEBS Journal, 2026. Written by Yoshiaki Nakayama and 15 co-authors. Institution: Laboratory of Microbial Chemistry, Kobe Pharmaceutical University, Kobe, Japan. Major MEDLINE topics: Receptor, IGF Type 1, Insulin-Like Growth Factor I, Insulin. 19 references. Funded by: Japan Society for the Promotion of Science.
Abstract (original language)
Neudesin, a secreted protein implicated in diverse physiological processes, such as metabolism and immunity, lacks an identified receptor, which has prevented a detailed understanding of its molecular mechanisms. In this study, we aimed to elucidate the function of neudesin by identifying its cognate receptor and investigating its effects on cellular signaling. Using a combination of phage display, bioinformatics, and biochemical analysis, we identified insulin‐like growth factor 1 receptor (IGF1R) as a high‐affinity receptor for neudesin, with a binding affinity of 1.78 ± 1.87 n m . This interaction was mediated by a conserved tryptophan‐proline‐glutamic acid (WPE) motif in the IGF1R extracellular domain. Our cellular assays revealed that, while neudesin binding to IGF1R induces basal phosphorylation of the downstream signaling molecules extracellular signal‐regulated kinase (ERK) and AKT (also known as Protein Kinase B, or PKB) in a cell‐line‐specific manner, it consistently acts as a negative modulator, attenuating both IGF1‐ and insulin‐induced signaling. Mechanistically, neudesin promoted the downregulation of cell surface IGF1R, thereby reducing the receptor pool available for ligand stimulation. Furthermore, neudesin inhibited insulin signaling, likely through the co‐internalization of IGF1R/insulin receptor (INSR) hybrid complexes. The physiological significance of this role was underscored in 3 T3‐L1 adipocytes, where neudesin knockdown enhanced insulin‐induced signaling and accelerated triglyceride accumulation. These results establish a novel molecular link between neudesin and the IGF1/insulin signaling axis, suggesting that neudesin may serve as an endogenous modulator of IGF1R/insulin activity, with potential implications for metabolic and growth‐related diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Microbial Chemistry, Kobe Pharmaceutical University, Kobe, Japan.
- Laboratory of Molecular Pathogenesis, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Molecular Pharmaceutics, Hoshi University, Tokyo, Japan.
- Laboratory of Biochemistry, Kobe Pharmaceutical University, Kobe, Japan.
- Laboratory of Biophysical Chemistry, Kobe Pharmaceutical University, Kobe, Japan.
ORCID profiles: Yoshiaki Nakayama, Hiroshi Kitagawa, Morichika Konishi
Funding
- Japan Society for the Promotion of Science
Cite
APA
Nakayama, Y., Nonaka, M., Masuda, Y., Matsumoto, H., Higashi, K., Pak, Y., Komoda, S., Tagawa, A., Shimizu, R., Mikami, T., Nadanaka, S., Yamasaki, T., Sano, K., Mukai, T., Kitagawa, H., & Konishi, M. (2026). Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motif. The FEBS Journal. https://doi.org/10.1111/febs.70566
Vancouver
Nakayama Y, Nonaka M, Masuda Y, Matsumoto H, Higashi K, Pak Y, et al. Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motif. The FEBS Journal. 2026. doi:10.1111/febs.70566
BibTeX
@article{Nakayama2026,
author = {Nakayama, Yoshiaki and Nonaka, Motohiro and Masuda, Yuki and Matsumoto, Hikaru and Higashi, Katsuaki and Pak, Yangha and Komoda, Satsuki and Tagawa, Ayami and Shimizu, Ryohei and Mikami, Tadahisa and Nadanaka, Satomi and Yamasaki, Toshihide and Sano, Kohei and Mukai, Takahiro and Kitagawa, Hiroshi and Konishi, Morichika},
title = {Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motif},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70566}
}
EUVIMED